1. Home
  2. PCRX vs AIV Comparison

PCRX vs AIV Comparison

Compare PCRX & AIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pacira BioSciences Inc.

PCRX

Pacira BioSciences Inc.

HOLD

Current Price

$23.21

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Logo Apartment Investment and Management Company

AIV

Apartment Investment and Management Company

HOLD

Current Price

$4.19

Market Cap

837.1M

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
PCRX
AIV
Founded
2006
1975
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
837.1M
IPO Year
2010
1996

Fundamental Metrics

Financial Performance
Metric
PCRX
AIV
Price
$23.21
$4.19
Analyst Decision
Strong Buy
Buy
Analyst Count
5
1
Target Price
$37.60
$10.00
AVG Volume (30 Days)
754.0K
3.5M
Earning Date
05-15-2026
06-01-2026
Dividend Yield
N/A
87.41%
EPS Growth
107.44
616.00
EPS
0.16
3.87
Revenue
$541,533,000.00
$138,486,000.00
Revenue This Year
$9.77
N/A
Revenue Next Year
$9.71
N/A
P/E Ratio
$145.38
$1.09
Revenue Growth
26.04
N/A
52 Week Low
$18.80
$4.19
52 Week High
$27.99
$8.89

Technical Indicators

Market Signals
Indicator
PCRX
AIV
Relative Strength Index (RSI) 52.99 18.73
Support Level $20.09 N/A
Resistance Level $24.65 $5.82
Average True Range (ATR) 1.11 0.10
MACD 0.06 -0.04
Stochastic Oscillator 66.38 1.23

Price Performance

Historical Comparison
PCRX
AIV

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.

About AIV Apartment Investment and Management Company

Apartment Investment & Management Co is a self-managed real estate investment trust. It is focused on property development, redevelopment and various other value-creating investment strategies, targeting the U.S multifamily market. Its operating segments are Development and Redevelopment; Operating, and Other. Development and Redevelopment segment consists of properties that are under construction or have not achieved stabilization, as well as land held for development. Operating segment includes 20 residential apartment communities with 5,243 apartment homes that have achieved a stabilized level of operations. Other segment includes The Benson Hotel, company's only hotel. Majority of revenue is gained from Operating Segment.

Share on Social Networks: